Cargando…
Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrat...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626775/ https://www.ncbi.nlm.nih.gov/pubmed/23531357 http://dx.doi.org/10.1186/1755-8794-6-10 |
_version_ | 1782266244554031104 |
---|---|
author | Talseth-Palmer, Bente A Holliday, Elizabeth G Evans, Tiffany-Jane McEvoy, Mark Attia, John Grice, Desma M Masson, Amy L Meldrum, Cliff Spigelman, Allan Scott, Rodney J |
author_facet | Talseth-Palmer, Bente A Holliday, Elizabeth G Evans, Tiffany-Jane McEvoy, Mark Attia, John Grice, Desma M Masson, Amy L Meldrum, Cliff Spigelman, Allan Scott, Rodney J |
author_sort | Talseth-Palmer, Bente A |
collection | PubMed |
description | BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrations which could contribute to the increased risk of cancer in HNPCC/LS patients. METHODS: Individuals diagnosed with HNPCC/LS (100) and healthy controls (384) were genotyped using the Illumina Human610-Quad SNP-arrays. Copy number variation (CNV) calling and association analyses were performed using Nexus software, with significant results validated using QuantiSNP. TaqMan Copy-Number assays were used for verification of CNVs showing significant association with HNPCC/LS identified by both software programs. RESULTS: We detected copy number (CN) gains associated with HNPCC/LS status on chromosome 7q11.21 (28% cases and 0% controls, Nexus; p = 3.60E-20 and QuantiSNP; p < 1.00E-16) and 16p11.2 (46% in cases, while a CN loss was observed in 23% of controls, Nexus; p = 4.93E-21 and QuantiSNP; p = 5.00E-06) via in silico analyses. TaqMan Copy-Number assay was used for validation of CNVs showing significant association with HNPCC/LS. In addition, CNV burden (total CNV length, average CNV length and number of observed CNV events) was significantly greater in cases compared to controls. CONCLUSION: A greater CNV burden was identified in HNPCC/LS cases compared to controls supporting the notion of higher genomic instability in these patients. One intergenic locus on chromosome 7q11.21 is possibly associated with HNPCC/LS and deserves further investigation. The results from this study highlight the complexities of fluorescent based CNV analyses. The inefficiency of both CNV detection methods to reproducibly detect observed CNVs demonstrates the need for sequence data to be considered alongside intensity data to avoid false positive results. |
format | Online Article Text |
id | pubmed-3626775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36267752013-04-16 Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients Talseth-Palmer, Bente A Holliday, Elizabeth G Evans, Tiffany-Jane McEvoy, Mark Attia, John Grice, Desma M Masson, Amy L Meldrum, Cliff Spigelman, Allan Scott, Rodney J BMC Med Genomics Research Article BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrations which could contribute to the increased risk of cancer in HNPCC/LS patients. METHODS: Individuals diagnosed with HNPCC/LS (100) and healthy controls (384) were genotyped using the Illumina Human610-Quad SNP-arrays. Copy number variation (CNV) calling and association analyses were performed using Nexus software, with significant results validated using QuantiSNP. TaqMan Copy-Number assays were used for verification of CNVs showing significant association with HNPCC/LS identified by both software programs. RESULTS: We detected copy number (CN) gains associated with HNPCC/LS status on chromosome 7q11.21 (28% cases and 0% controls, Nexus; p = 3.60E-20 and QuantiSNP; p < 1.00E-16) and 16p11.2 (46% in cases, while a CN loss was observed in 23% of controls, Nexus; p = 4.93E-21 and QuantiSNP; p = 5.00E-06) via in silico analyses. TaqMan Copy-Number assay was used for validation of CNVs showing significant association with HNPCC/LS. In addition, CNV burden (total CNV length, average CNV length and number of observed CNV events) was significantly greater in cases compared to controls. CONCLUSION: A greater CNV burden was identified in HNPCC/LS cases compared to controls supporting the notion of higher genomic instability in these patients. One intergenic locus on chromosome 7q11.21 is possibly associated with HNPCC/LS and deserves further investigation. The results from this study highlight the complexities of fluorescent based CNV analyses. The inefficiency of both CNV detection methods to reproducibly detect observed CNVs demonstrates the need for sequence data to be considered alongside intensity data to avoid false positive results. BioMed Central 2013-03-26 /pmc/articles/PMC3626775/ /pubmed/23531357 http://dx.doi.org/10.1186/1755-8794-6-10 Text en Copyright © 2013 Talseth-Palmer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Talseth-Palmer, Bente A Holliday, Elizabeth G Evans, Tiffany-Jane McEvoy, Mark Attia, John Grice, Desma M Masson, Amy L Meldrum, Cliff Spigelman, Allan Scott, Rodney J Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients |
title | Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients |
title_full | Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients |
title_fullStr | Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients |
title_full_unstemmed | Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients |
title_short | Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients |
title_sort | continuing difficulties in interpreting cnv data: lessons from a genome-wide cnv association study of australian hnpcc/lynch syndrome patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626775/ https://www.ncbi.nlm.nih.gov/pubmed/23531357 http://dx.doi.org/10.1186/1755-8794-6-10 |
work_keys_str_mv | AT talsethpalmerbentea continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT hollidayelizabethg continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT evanstiffanyjane continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT mcevoymark continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT attiajohn continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT gricedesmam continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT massonamyl continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT meldrumcliff continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT spigelmanallan continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients AT scottrodneyj continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients |